EUVIMEDEUVIMED entdecken
Crossref

Genome-wide CRISPR Identification of Regulators Governing the NLRP3 Inflammasome 2331537

Huan He, Patricia Hsieh, Sunnie Yoh, Jun Li, Sumit Chanda

The Journal of Immunology · 01.08.2026 · 215 (Supplement_1)

DOI: 10.1093/jimmun/vkag141.1808 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, online erschienen am 28.07.2026. Verfasst von Huan He und 4 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Dysregulated NLRP3 inflammasome activation drives chronic inflammation in autoimmune and autoinflammatory diseases. Sustained NLRP3-dependent IL-1β production promotes tissue damage, yet current therapies rely on broad immunosuppression or cytokine blockade that can impair host defense and provide incomplete disease control. Although direct NLRP3 inhibitors are emerging, their utility is limited by toxicity and an incomplete understanding of inflammasome regulation. Defining genetic networks that tune inflammasome activation is therefore critical for identifying therapeutic targets that selectively limit pathological inflammation while preserving protective innate immune responses.

Methods

We conducted a genome-wide CRISPR—Cas9 KO screen in human THP-1 macrophages stably expressing ASC-GFP to identify genetic regulators of NLRP3 inflammasome activation. After inflammasome activation, cells are sorted by flow cytometry based on ASC speck formation. Candidate genes were prioritized using enrichment statistics and pathway analysis. Top hits were validated using independent sgRNAs, with readouts including IL-1β ELISA and imaging-based ASC speck quantification. NF-κB phosphorylation was assessed to exclude false-positive regulators affecting inflammasome priming rather than activation.

Results

The screen robustly identified known NLRP3 pathway components, validating screen performance, and revealed multiple previously uncharacterized regulators spanning cytoskeletal dynamics, mitochondrial homeostasis, and ubiquitin signaling. Genetic perturbation of top candidates significantly altered IL-1β release without affecting NF-κB priming.

Conclusion

Our study defines a comprehensive genetic landscape governing human NLRP3 inflammasome activation and uncovers novel regulatory nodes that decouple inflammasome assembly from upstream priming. These findings provide mechanistic insight into innate immune regulation and nominate new targets for selective therapeutic modulation of inflammasome-driven disease. Funding Source n/a Topic Categories Innate Immune Responses and Host Defense: Molecular Mechanisms (INM)

Zitieren

APA

He, H., Hsieh, P., Yoh, S., Li, J., & Chanda, S. (2026). Genome-wide CRISPR Identification of Regulators Governing the NLRP3 Inflammasome 2331537. The Journal of Immunology, 215(Supplement_1). https://doi.org/10.1093/jimmun/vkag141.1808

Vancouver

He H, Hsieh P, Yoh S, Li J, Chanda S. Genome-wide CRISPR Identification of Regulators Governing the NLRP3 Inflammasome 2331537. The Journal of Immunology. 2026;215(Supplement_1). doi:10.1093/jimmun/vkag141.1808

BibTeX
@article{He2026,
  author = {He, Huan and Hsieh, Patricia and Yoh, Sunnie and Li, Jun and Chanda, Sumit},
  title = {Genome-wide CRISPR Identification of Regulators Governing the NLRP3 Inflammasome 2331537},
  journal = {The Journal of Immunology},
  year = {2026},
  volume = {215},
  number = {Supplement_1},
  doi = {10.1093/jimmun/vkag141.1808}
}
Kostenlos starten →